Bio-Rad Laboratories Other Current Liabilities

Bio-Rad Laboratories (BIO.B) currently reports a other current liabilities of $340M as of June 2026. That compares with $160M in the prior-year period — up 118.0% year over year. Use the charts on this page to explore Bio-Rad Laboratories's other current liabilities history and peer comparisons.

Bio-Rad Laboratories's other current liabilities increased from $160M to $340M — a 118.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bio-Rad Laboratories reported $340M in other current liabilities as of June 2026. That compares with $160M in the prior-year period — up 118.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $340M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bio-Rad Laboratories, and consider following BIO.B for alerts when major investors trade the stock.

Bio-Rad Laboratories is classified in the Healthcare sector. On other current liabilities, it currently shows $340M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIO.B with unrelated industries.